Takayasu arteritis: Assessment of response to medical therapy based on clinical activity criteria and imaging techniques

Rheumatology International

Volumn 32, Issue 3, 2012, Pages 703-709

  Freitas, Daniele Souza ^a   Camargo, Cintia Zumstein ^a   Mariz, Henrique Ataíde ^a   Arraes, Anne Elizabeth Diniz ^a   De Souza, Alexandre Wagner Silva ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Cohort studies; Immunosuppressive agents; Takayasu arteritis; Vasculitides

Indexed keywords

ADALIMUMAB; AZATHIOPRINE; CYCLOPHOSPHAMIDE; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; LEFLUNOMIDE; METHOTREXATE; MYCOPHENOLIC ACID; PREDNISONE; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; GLUCOCORTICOID;

ABDOMINAL AORTA; ADULT; ANGIOGRAPHY; AORTA ARCH; AORTA ARCH SYNDROME; AORTA VALVE REGURGITATION; AORTA VALVE REPLACEMENT; ARTERY BYPASS; ARTICLE; ASCENDING AORTA; BLOOD VESSEL GRAFT; BRACHIOCEPHALIC TRUNK; BRAZIL; CELIAC ARTERY; COHORT ANALYSIS; COMMON CAROTID ARTERY; DESCENDING AORTA; DISEASE ACTIVITY; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG SUBSTITUTION; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HUMAN; ILIAC ARTERY; IMMUNOSUPPRESSIVE TREATMENT; INFERIOR MESENTERIC ARTERY; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; POSTOPERATIVE PERIOD; PRESCRIPTION; PRIORITY JOURNAL; RELAPSE; REMISSION; RENAL ARTERY; RESTENOSIS; RETROSPECTIVE STUDY; STENT; SUBCLAVIAN ARTERY; SUPERIOR MESENTERIC ARTERY; SURVIVAL RATE; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT; VERTEBRAL ARTERY; DRUG COMBINATION; PATHOLOGY; PATHOPHYSIOLOGY; RECURRENT DISEASE; STENOSIS, OCCLUSION AND OBSTRUCTION; TREATMENT OUTCOME; VASCULAR PATENCY;

ADULT; AORTA, ABDOMINAL; CONSTRICTION, PATHOLOGIC; DRUG SUBSTITUTION; DRUG THERAPY, COMBINATION; FEMALE; GLUCOCORTICOIDS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LONGITUDINAL STUDIES; MALE; METHOTREXATE; PREDNISONE; RECURRENCE; REMISSION INDUCTION; RETROSPECTIVE STUDIES; SUBCLAVIAN ARTERY; TAKAYASU ARTERITIS; TREATMENT OUTCOME; VASCULAR PATENCY;

EID: 84863316619     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-010-1694-9     Document Type: Article

References (32)

1. Kerr GS, Hallahan CW, Giordano J et al (1994) Takayasu Arteritis. Ann Intern Med 120:919-929 (Pubitemid 24179154)
2. Johnston SL, Lock RJ, Gompels MM (2002) Takayasu arteritis: a review. J Clin Pathol 55:481-486 (Pubitemid 34779296)
3. Sato EI, Hatta FS, Levy-Neto M, Fernades S (1998) Demographic, clinical, and angiographic data of patients with Takayasu arteritis in Brazil. Int J Cardiol 66(Supp 1):S67-S70
4. Vanoli M, Daina E, Salvarani C et al (2005) Takayasu's arteritis: a study of 104 italian Patients. Arthritis Rheum 53:100-107 (Pubitemid 40216358)
5. Soto ME, Espinola N, Flores-Suarez LF, Reyes PA (2008) Takayasu arteritis: clinical features in 110 Mexican Mestizo patients and cardiovascular impact on survival and prognosis. Clin Exp Rheumatol 26(3 Suppl 49):S9-S15
6. Park MC, Lee SW, Park YB, Chung NS, Lee SK (2005) Clinical characteristics and outcomes of Takayasu's arteritis: analysis of 108 patients using standardized criteria for diagnosis, activity assessment, and angiographic classification. Scand J Med 34:284-292 (Pubitemid 41215662)
7. Ishikawa K, Maetani S (1994) Long-term outcome of for 120 Japanese patients with Takayasu's disease: clinical and statistical analysis of related prognostic factors. Circulation 90:1855-1860 (Pubitemid 24320935)
8. Sharma BK, Jain S (1998) A possible role of sex in determining distribution of lesions in Takayasu arteritis. Int J Cardiol 66(Suppl 1):S81-S84 (Pubitemid 29037934)
9. Numano F (1997) DiVerences in clinical presentation and outcome in different countries for Takayasu's arteritis. Curr Opin Rheumtol 9:12-15 (Pubitemid 27217763)
10. Numano F, Okawara M, Inomata H, Kobayashi Y (2000) Takayasu's arteritis. Lancet 356:1023-1025
11. Maksimowicz-McKinnon K, Clark TM, HoVman GS (2007) Limitations of therapy and a guarded prognosis in an American cohort of Takayasu arteritis patients. Arthritis Rheum 56:1000-1009 (Pubitemid 46399449)
12. HoVman GS, Leavitt RY, Kerr GS et al (1994) Treatment of glucocorticoid-resistant or relapsing Takayasu artertitis with methotrexate. Arthritis Rheum 37:578-582 (Pubitemid 24115946)
13. Valsakumar AK, Chirammal Valappil U, Jorapor V et al (2003) Role of immunosuppressive therapy on clinical, immunological, and angiographic outcome in active Takayasu's arteritis. J Rheumatol 30:1793-1798 (Pubitemid 36962457)
14. Shinjo SK, Pereira RMR, Tizziani VAP et al (2007) Mycophenolate mofetil reduces disease activity and steroid dosage in Takayasu arteritis. Clin Rheumatol 26:1871-1875 (Pubitemid 47516967)
15. Daina E, Schieppati A, Remuzzi G (1999) Mycophenolate mofetil for the treatment of Takayasu arteritis. Ann Intern Med 130:422-426 (Pubitemid 29111224)
16. HoVman GS, Merkel PA, Brasington RD et al (2004) Anti-tumor necrosis factor therapy in patients with difficult to treat Takayasu's arteritis. Arthritis Rheum 50:2296-2304 (Pubitemid 38924409)
17. Molloy ES, Langford CA, Clark TM, Gota CE, HoVman GS (2008) Anti-tumour necrosis factor therapy in patients with refractory Takayasu arteritis: long-term follow-up. Ann Rheum Dis 67:1567-1569
18. Hitoshi O, Matsuda H, Minatoya K et al (2008) Overview of late outcome of medical and surgical treatment for Takayasu arteritis. Circulation 118:2738-2747
19. HoVman GS, Liang P (2004) Advances in the medical and surgical treatment of Takayasu arteritis. Curr Opin Rheumatol 17:16-24
20. Miyata T, Sato O, Koyama H, Shigematsu H, Tada Y (2003) Long-term survival after surgical treatment of patients with Takayasùs arteritis. Circulation 23:1474-1480 (Pubitemid 37176454)
21. Arend WP, Michel BA, Bloch DA et al (1990) The American College of Rheumatology 1990 criteria for the classification of Takaysu arteritis. Arthritis Rheum 33:1129-1134 (Pubitemid 20273298)
22. Hata A, Noda M, Moriwaki R, Numano F (1996) Angiographic Wndings of Takayasu arteritis: new classification. Int J Cardiol 54(suppl):S155-S163
23. Bicakcigil M, Aksu K, Kamali S et al (2009) Takayasu arteritis in Turkey-clinical and angiographic features of 248 patients. Clin Exp Rheumatol 27(Suppl 52):S59-S64
24. Arnaud L, Haroche J, Limal N et al (2010) Takayasu arteritis in France: a single-center retrospective study of 82 cases comparing White, North African and Black patients. Medicine (Baltimore) 89:1-17
25. Sato EI, Lima DNS, Espirito Santo B, Hata F (2000) Takayasu arteritis-treatment and prognosis in a University Center in Brazil. Int J Cardiol 75:S163-S166
26. Jain S, Kumari S, Ganguly NK, Sharma BK (1996) Current status of Takayasu arteritis in India. Int J Cardiol 54(Suppl):S111-S116
27. Ueda H, Morooka S, Ito I, Yamaguchi H, Takeda T (1969) Clinical observation of 52 cases of aortitis syndrome. Jpn Heart J 10:277-288
28. Karageorgaki ZT, Bertsias GK, Mavragani CP et al (2009) Takayasu arteritis: epidemiological, clinical, and immunogenetic features in Greece. Clin Exp Rheumatol 27(Suppl 52):S33-S39
29. Maksimowicz-McKinnon K, HoVman GS (2007) Takayasu arteritis: what is the long term prognosis? Rheum Dis Clin N Am 33:777-786
30. Shelhamer JH, Volkman DJ, Parrillo JE et al (1985) Takayasùs arteritis and its therapy. Ann Intern Med 103:121-126
31. Park MC, Lee SW, Park YB et al (2006) Post-interventional immunosuppressive treatment and vascular restenosis in Takayasùs arteritis. Rheumatology (Oxford) 45:600-605
32. Subramanyan R, Joy J, Balakrishnan KG (1989) Natural history of aortoarteritis (Takayasùs disease). Circulation 80:429-437 (Pubitemid 19231376)